| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/15/1993 | EP0494904B1 Device for oral administration of an active principle for preventive treatment of caries in babies |
| 09/15/1993 | EP0490991B1 Dosage form for administering oral hypoglycemic glipizide |
| 09/15/1993 | EP0458950B1 Stabilization of k2p pro |
| 09/15/1993 | EP0457916B1 Plasma-irradiated solid preparation |
| 09/15/1993 | EP0442949B1 Adhesive drug delivery composition |
| 09/15/1993 | EP0387300B1 Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained |
| 09/15/1993 | EP0276278B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 09/15/1993 | CN1076124A A process for preparing oral drug coated containing compounds unstable to acid |
| 09/15/1993 | CN1076112A Change of lentinan powder to liquid for intravenous injection |
| 09/14/1993 | US5244881 Compositions based on imipyramine |
| 09/14/1993 | US5244880 Stable aqueous solutions of prymicin and pharmaceutical and cosmetic compositions containing these solutions |
| 09/14/1993 | US5244816 Method for purifying chelator conjugated compounds |
| 09/14/1993 | US5244689 Flour substitute not made from grains |
| 09/14/1993 | US5244672 Composition containing liposomes stabilized by a stabilizing support based on atelocollagen and glycosaminoglycans |
| 09/14/1993 | US5244652 Viscous surface active composition |
| 09/14/1993 | US5244096 Condom; providone-iodine; microbial agent for use as mouthwash |
| 09/14/1993 | CA1322172C Antiviral pharmaceutical compositions containing cyclodextrin |
| 09/14/1993 | CA1322170C Use of ethylene oxide/propylene oxide block copolymers for controlling foam in liquid pharmaceutical formulations, pharmaceutical formulations, and a process for their preparation |
| 09/14/1993 | CA1322166C Process for the preparation of collagen and obtained product |
| 09/14/1993 | CA1322162C Formulation for extending the shelf life of food products, medicaments and cosmetic products |
| 09/14/1993 | CA1322156C Metal complex-containing pharmaceutical agents |
| 09/13/1993 | CA2091521A1 Method for producing carbohydrates |
| 09/11/1993 | CA2091399A1 Pranoprofen-containing, suspending medicinal composition |
| 09/10/1993 | CA2091195A1 Poultry color-coded inactivated vaccines |
| 09/08/1993 | EP0559262A1 Stabilized peroxide gels containing fluoride |
| 09/08/1993 | EP0558779A1 Compositions containing ranitidine/bismuth carboxylates salts |
| 09/08/1993 | EP0558749A1 Antisense nucleic acid derivative |
| 09/08/1993 | EP0558586A1 A gel-forming liquid carrier composition. |
| 09/08/1993 | EP0449960B1 Heat-dehydrated emulsion compositions |
| 09/08/1993 | EP0441833B1 Dosage form having reduced abuse potential |
| 09/08/1993 | EP0325613B1 Penetration enhancers for transdermal delivery of systemic agents |
| 09/08/1993 | CN1075970A Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
| 09/08/1993 | CN1022023C Process for liquid pharmaceutical composition containing piperidinoalkanol derivatives |
| 09/08/1993 | CN1022022C Method for preparing hydrated adhesive gel |
| 09/07/1993 | US5242951 Estrogen-containing gel preparation |
| 09/07/1993 | US5242910 Sustained release compositions for treating periodontal disease |
| 09/07/1993 | US5242824 Monoclonal antibody to human carcinomas |
| 09/07/1993 | US5242813 Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
| 09/07/1993 | US5242397 Treating a blood vessel containing atherosclerotic lesion |
| 09/07/1993 | CA2130670A1 Improvements in or relating to contrast agents |
| 09/05/1993 | CA2107558A1 In vivo binding pair pretargeting |
| 09/04/1993 | WO1993017702A1 Oral vaccine |
| 09/04/1993 | CA2131442A1 Oral vaccine |
| 09/02/1993 | WO1993017102A1 MODULATIONS OF CELLULAR FUNCTIONS WITH HnRNP PROTEINS |
| 09/02/1993 | WO1993017095A1 In vitro activation of cytotoxic t cells |
| 09/02/1993 | WO1993017038A1 Methods of treating diabetes |
| 09/02/1993 | WO1993017033A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | WO1993017030A1 Immunological detection of organophosphates |
| 09/02/1993 | WO1993017001A1 N-[(1,3,5-triazine-2-yl)aminocarbonyl]benzene sulphonamide herbicides |
| 09/02/1993 | WO1993016735A1 Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor |
| 09/02/1993 | WO1993016734A1 Use of the conjugate of a fgf and a saporin for treatment of ocular pathologies |
| 09/02/1993 | WO1993016733A1 Topical composition containing hyaluronic acid and nsaids |
| 09/02/1993 | WO1993016732A1 Formulations containing hyaluronic acid |
| 09/02/1993 | WO1993016731A1 A pH SENSITIVE, REVERSIBLE GELLING, ERODIBLE DRUG DELIVERY SYSTEM |
| 09/02/1993 | WO1993016707A1 Linseed mucilage |
| 09/02/1993 | WO1993016688A1 Facilitated oxygen delivery in conjunction with hemodilution |
| 09/02/1993 | WO1993016687A1 Gels for encapsulation of biological materials |
| 09/02/1993 | WO1993016686A1 Pharmaceutical preparation for sustained release of a drug and process for producing the same |
| 09/02/1993 | WO1993016658A1 Use of injectable biomaterials for the repair and augmentation of the anal sphincters |
| 09/02/1993 | WO1993016657A1 Injectable ceramic compositions and methods for their preparation and use |
| 09/02/1993 | DE4206146A1 Herbizide n-((1,3,5-triazin-2-yl)aminocarbonyl)benzolsulfonamide Herbicidal N - ((1,3,5-triazin-2-yl) aminocarbonyl) benzenesulfonamide |
| 09/02/1993 | DE4205938A1 New immuno-toxin contg. CD30 monoclonal antibody - is coupled to type 1 ribosome inactivating protein toxin, for selective elimination of CD30 cells, esp. treatment of Hodgkins disease |
| 09/02/1993 | CA2131032A1 Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor |
| 09/02/1993 | CA2130438A1 Use of the conjugate of a fgf and a saporin for treatment of ocular pathologies |
| 09/02/1993 | CA2130350A1 Linseed mucilage |
| 09/02/1993 | CA2130182A1 Methods of treating diabetes |
| 09/02/1993 | CA2129987A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | CA2129739A1 Herbicidal n-[(1,3,5-triazin-2-yl)-aminocarbonyl]-benzenesulfonamides |
| 09/01/1993 | EP0557512A1 Utilization in cosmetic or topical applications of an aqueous dispersion based on organopolysiloxanes and a crosslinked copolymer of acrylamide/neutralized 2-acrylamido 2-methylpropane sulfonic acid. |
| 09/01/1993 | EP0527954A4 Molecular recognition units |
| 09/01/1993 | EP0456764B1 Fat emulsion for endotracheal application, its production and use |
| 09/01/1993 | EP0335982B1 Gelatin composition |
| 09/01/1993 | CN1075631A Drug with the effect of resisting and preventing tension and intelligence-promoting |
| 08/31/1993 | US5241072 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
| 08/31/1993 | US5241060 Base moiety-labeled detectable nucleatide |
| 08/31/1993 | US5241053 Glycoprotein of Herpes simplex virus type 1 and heat-labile enterotoxin B subunit; enhanced absorption for immunization through nasal mucosa |
| 08/31/1993 | US5240995 Electrotransport adhesive |
| 08/31/1993 | US5240963 Branched polyanhydrides |
| 08/31/1993 | US5240932 Percutaneously absorbable compositions of morphine or analogous analgesics of morphine |
| 08/31/1993 | US5240917 Suppression of thromboxane levels by percutaneous administration of aspirin |
| 08/31/1993 | US5240914 Administering conjugate of glucuronic acid and (di)thiocarbamate |
| 08/31/1993 | US5240693 Image enhancement by coadministration of biomodulators and structurally modified imaging agents |
| 08/31/1993 | US5240662 Process for the preparation of solid pharmaceutical compositions |
| 08/31/1993 | CA1321849C Adhesive compositions, controlled release compositions and transdermal drug delivery device |
| 08/28/1993 | WO1993016684A1 Cosmetic or dermatological composition in the form of an oil-in-water dispersion capable of forming composite films |
| 08/28/1993 | CA2109195A1 Cosmetic or dermatological composition in the form of an oil-in-water dispersion capable of forming composite films |
| 08/25/1993 | WO1993016685A1 Bioartificial endocrine device |
| 08/25/1993 | EP0557199A1 Polyethyleneglycol hirudin conjugate, process of preparation and use in the cure of thrombosis |
| 08/25/1993 | EP0557065A1 Spheroid formulation |
| 08/25/1993 | EP0557064A1 Modified release formulation |
| 08/25/1993 | EP0556818A1 Polyester type polyfunctional macromonomer, gel and drug release controlling material responsive to changes in temperature |
| 08/25/1993 | EP0556394A1 Lyophilized preparation and production thereof |
| 08/25/1993 | EP0556392A1 Process for producing fat emulsion |
| 08/25/1993 | EP0556388A1 Antiviral agent |
| 08/25/1993 | EP0556239A1 Aerosol containing medicaments. |
| 08/25/1993 | EP0556197A1 Prolonging expression of polynucleotides introduced into a cell |
| 08/25/1993 | EP0556178A1 Use of protease nexin-i to mediate wound healing |
| 08/25/1993 | EP0391893B1 Porous microspheres for drug delivery and methods for making same |
| 08/24/1993 | US5239062 Blocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicity |
| 08/24/1993 | US5238944 Viricides comprising isotearic acid; skin disorders |